Skip to content

Repligen RGEN Book value per share

Book value per share at other companies

TEC
Bio-TechneTECH
$13.25+4.3%
Revvity logo
RevvityRVTY
$64.20+1.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$139.23+6.8%
Danaher logo
DanaherDHR
$74.45+5.5%
Agilent Technologies logo
Agilent TechnologiesA
$25.17+16.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$254.15+6.4%

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

Based on the most recent quarter.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's book value per share?
Repligen (RGEN) reported book value per share of $37.16 in Q1 2026.
How has Repligen's book value per share changed year-over-year?
Repligen's book value per share increased by 5.8% year-over-year, from $35.11 to $37.16.
What is the long-term trend for Repligen's book value per share?
Over 3 years (2020 to 2023), Repligen's book value per share has grown at a 7.1% compound annual growth rate (CAGR), from $28.37 to $34.85.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.